Drug Interactions and Side Effects of Humira and Isophane Insulin and Lansoprazole and Acetaminophen W/ Codeine and Prednisone and Cyanocobalamin and Tocopherol Concentrate Cap and Ascorbic Acid and Multi-vitamin and Calcium Gluconate and Risedronate Sodium
>>> Check drugs in a new way
| Report ID | Date of report | Patient age | Patient gender |
| 66034 | Mar, 7, 2006 | Not specified | Male |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Humira | adalimumab |
Isophane Insulin | insulin susp isophane recombinant human |
Lansoprazole | lansoprazole |
Acetaminophen W/ Codeine | acetaminophen; codeine phosphate |
Prednisone | prednisone |
Cyanocobalamin | cyanocobalamin |
Tocopherol Concentrate Cap | alpha-tocopherol acetate; ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin k |
Ascorbic Acid | ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e |
Multi-vitamin | ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e; vitamin k |
Calcium Gluconate | quinidine gluconate |
Risedronate Sodium | risedronate sodium |
| Name |
Clostridial Infection |
Results from eHealthMe : 3 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Clostridial Infection | 1 (33.33%) |
Top 3 (total: 0. Click here to see more) co-used drugs - potential interacting drugs:
Death reported: 1 (33.33% of total reports)
| Name | Count (% of total reports) |
Unevaluable Event | 1 (33.33%) |
Pneumonia | 1 (33.33%) |
Death | 1 (33.33%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports: